genenews ltd (GEN:Toronto)
genenews ltd (GEN) Snapshot
|
Open
C$0.98
|
Previous Close
C$0.98
|
|
|
Day High
C$0.99
|
Day Low
C$0.98
|
|
|
52 Week High
01/22/13 - C$1.09
|
52 Week Low
09/26/12 - C$0.39
|
|
|
Market Cap
33.1M
|
Average Volume 10 Days
22.9K
|
|
|
EPS TTM
C$-0.22
|
Shares Outstanding
33.7M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
genenews ltd (GEN) Related Businessweek News
No Related Businessweek News Foundgenenews ltd (GEN) Details
GeneNews Limited, a molecular diagnostics company, focuses on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. Its core platform technology, the Sentinel Principle, detects and stages various diseases or medical conditions from a blood sample. The company is applying the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases, and neurological disorders. Its lead product includes ColonSentry, a blood-based molecular test to pre-screen and assess an individual’s risk of having colorectal cancer. The company was formerly known as ChondroGene Limited and changed its name to GeneNews Limited in October 2006. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada.
genenews ltd (GEN) Top Compensated Officers
genenews ltd (GEN) Key Developments
GeneNews Limited reported earnings results for the first quarter ended March 31, 2013. For the three months ended March 31, 2013, total revenues were $48,348 as compared to $6,477 in the same period in 2012. The net loss for the first quarter of 2013 was approximately $1.5 million or $0.05 loss per common share, as compared to a net loss of approximately $1.2 million or $0.08 loss per common share for the same three-month period in 2012.
GeneNews Limited Presents at Bloom Burton & Co Healthcare Investor Conference, May-22-2013 02:30 PM. Venue: Toronto Board of Trade, 1 First Canadian Place, Toronto, ON M5X 1C1, Canada. Speakers: Gailina J. Liew, President, Chief Operating Officer, General Counsel, Secretary, Director, Member of Special Committee and Member of Strategy Committee.
GeneNews Limited announced that at the AGM to be held on May 28, 2013, the shareholders will consider and, if thought fit, pass a resolution to confirm By-Law No. 5 of the Corporation, being a by-law to amend By-Law No. 4 of the Corporation.
| Recently Viewed | |||
| GEN:CN | C$0.98 CAD | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for GEN. | |||
| View Industry Companies | |||
Industry Analysis
GEN
Industry Average
| Valuation | GEN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 91.7x |
|
| Price/Book | 8.2x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 64.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact GENENEWS LTD, please visit www.genenews.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
